Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape
- PMID: 15723810
- DOI: 10.1016/j.immuni.2005.01.006
Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape
Abstract
Major Histocompatibility Complex (MHC) class II molecules, including Human Leukocyte Antigen (HLA)-DR, present peptide fragments from proteins degraded in the endocytic pathway. HLA-DR is targeted to late-endocytic structures named MHC class II-containing Compartments (MIIC), where it interacts with HLA-DM. This chaperone stabilizes HLA-DR during peptide exchange and is critical for successful peptide loading. To follow this process in living cells, we have generated cells containing HLA-DR3/Cyan Fluorescent Protein (CFP), HLA-DM/Yellow Fluorescent Protein (YFP), and invariant chain. HLA-DR/DM interactions were observed by Fluorescence Resonance Energy Transfer (FRET). These interactions were pH insensitive, yet occurred only in internal structures and not at the limiting membrane of MIIC. In a cellular model of infection, phagosomes formed a limiting membrane surrounding internalized Salmonella. HLA-DR and HLA-DM did not interact in Salmonella-induced vacuoles, and HLA-DR was not loaded with antigens. The absence of HLA-DR/DM interactions at the limiting membrane prevents local loading of MHC class II molecules in phagosomes. This may allow these bacteria to successfully evade the immune system.
Similar articles
-
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.J Immunol. 1998 Oct 1;161(7):3282-91. J Immunol. 1998. PMID: 9759843
-
Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.Hum Immunol. 2005 Jan;66(1):43-55. doi: 10.1016/j.humimm.2004.10.002. Hum Immunol. 2005. PMID: 15620461
-
Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.J Immunol. 1996 Aug 1;157(3):1017-27. J Immunol. 1996. PMID: 8757605
-
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Oncogene. 2003 Sep 29;22(42):6564-9. doi: 10.1038/sj.onc.1206960. Oncogene. 2003. PMID: 14528281 Review.
-
How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.Hum Immunol. 1997 May;54(2):170-9. doi: 10.1016/s0198-8859(97)00077-3. Hum Immunol. 1997. PMID: 9297535 Review.
Cited by
-
Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.J Immunol. 2010 Dec 1;185(11):6608-16. doi: 10.4049/jimmunol.1001768. Epub 2010 Nov 3. J Immunol. 2010. PMID: 21048109 Free PMC article.
-
Capsular specific IgM enhances complement-mediated phagocytosis and killing of Cryptococcus neoformans by methamphetamine-treated J774.16 macrophage-like cells.Int Immunopharmacol. 2017 Aug;49:77-84. doi: 10.1016/j.intimp.2017.05.024. Epub 2017 May 25. Int Immunopharmacol. 2017. PMID: 28551495 Free PMC article.
-
Dynamic Changes in the Intracellular Association of Selected Rab Small GTPases with MHC Class II and DM during Dendritic Cell Maturation.Front Immunol. 2017 Mar 27;8:340. doi: 10.3389/fimmu.2017.00340. eCollection 2017. Front Immunol. 2017. PMID: 28396666 Free PMC article.
-
Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning.J Cell Biol. 2009 Jun 29;185(7):1209-25. doi: 10.1083/jcb.200811005. J Cell Biol. 2009. PMID: 19564404 Free PMC article.
-
Sibling rivalry: competition between MHC class II family members inhibits immunity.Nat Struct Mol Biol. 2013 Jan;20(1):7-10. doi: 10.1038/nsmb.2484. Nat Struct Mol Biol. 2013. PMID: 23288359
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous